EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitigation of Breast Cancer Cells’ Invasiveness via Down Regulation of ETV7, Hippo, and PI3K/mTOR Pathways by Vitamin D3 Gold-Nanoparticles

Moumita Roy iD, Fazle Hussain iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Moumita Roy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mechanical Engineering Department, Texas Tech University, Lubbock, TX 79409, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Cholecalciferol, Down-Regulation, Metal Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TTU President’s Distinguished Chair.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis in breast cancer is the major cause of death in females (about 30%). Based on our earlier observation that Vitamin D3 downregulates mTOR, we hypothesized that Vitamin D3 conjugated to gold nanoparticles (VD3-GNPs) reduces breast cancer aggressiveness by downregulating the key cancer controller PI3K/AKT/mTOR. Western blots, migration/invasion assays, and other cell-based, biophysical, and bioinformatics studies are used to study breast cancer cell aggressiveness and nanoparticle characterization. Our VD3-GNP treatment of breast cancer cells (MCF-7 and MDA-MB-231) significantly reduces the aggressiveness (cancer cell migration and invasion rates > 45%) via the simultaneous downregulation of ETV7 and the Hippo pathway. Consistent with our hypothesis, we, indeed, found a downregulation of the PI3K/AKT/mTOR pathway. It is surprising that the extremely low dose of VD3 in the nano formulation (three orders of magnitude lower than in earlier studies) is quite effective in the alteration of cancer invasiveness and cell signaling pathways. Clearly, VD3-GNPs are a viable candidate for non-toxic, low-cost treatment for reducing breast cancer aggressiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCholecalciferolDown-RegulationMetal NanoparticlesNeoplasm InvasivenessSignal TransductionFemaleHumansCell Line, TumorCell MovementGene Expression Regulation, NeoplasticGoldHippo Signaling PathwayMCF-7 CellsPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesTranscription Factors

Stichwörter der Autor:innen

AKTETVHippoPI3KVD3-GNP treatmentmTORpathway

Substanzen

CholecalciferolGoldMTOR protein, humanPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesTranscription Factors

Autor:innen und Institutionen

  • Mechanical Engineering Department, Texas Tech University, Lubbock, TX 79409, USA.

ORCID-Profile: Moumita Roy, Fazle Hussain

Förderung

  • TTU President’s Distinguished Chair

Zitieren

APA

Roy, M., & Hussain, F. (2024). Mitigation of Breast Cancer Cells’ Invasiveness via Down Regulation of ETV7, Hippo, and PI3K/mTOR Pathways by Vitamin D3 Gold-Nanoparticles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105348

Vancouver

Roy M, Hussain F. Mitigation of Breast Cancer Cells’ Invasiveness via Down Regulation of ETV7, Hippo, and PI3K/mTOR Pathways by Vitamin D3 Gold-Nanoparticles. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105348

BibTeX
@article{Roy2024,
  author = {Roy, Moumita and Hussain, Fazle},
  title = {Mitigation of Breast Cancer Cells’ Invasiveness via Down Regulation of ETV7, Hippo, and PI3K/mTOR Pathways by Vitamin D3 Gold-Nanoparticles},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105348}
}
Kostenlos starten →